Literature DB >> 2542366

Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis.

S A Halperin1, R Bortolussi, A J Wort.   

Abstract

Nasopharyngeal culture, direct immunofluorescence, and serology of acute-phase and paired serum specimens were compared for the laboratory diagnosis of infections due to Bordetella pertussis in a community-based pediatric population with both high vaccine usage and high pertussis incidence. In 77 (37%) of 210 patients evaluated, one or more tests were positive for pertussis. A clinical illness compatible with pertussis was present in 52 (71%) of 73 pertussis test-positive and 42 (35%) of 119 test-negative patients (P less than 0.001). Nasopharyngeal culture was of low sensitivity (20 [26%] of 77 positive tests) but was most commonly confirmed by another positive pertussis test (85%). Direct immunofluorescence was both insensitive and nonspecific; only 6 (30%) of 20 cases positive by culture were positive by immunofluorescence, and only 4 (33%) of 12 of the culture-negative, immunofluorescence-positive cases could be confirmed by another positive pertussis test. Although serology by enzyme immunoassay proved to be the most sensitive of the laboratory tests (87%), this sensitivity could be achieved only by assaying both acute-phase and paired serum specimens and measuring immunoglobulin G (IgG), IgA, and IgM antibodies to two pertussis antigens (pertussis toxin and filamentous hemagglutinin). Loss of sensitivity occurred with any reduction in the number of these serologic assays performed. Optimal laboratory diagnosis of endemic pertussis in a pediatric population requires both nasopharyngeal culture and serology by enzyme immunoassay.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542366      PMCID: PMC267411          DOI: 10.1128/jcm.27.4.752-757.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Enrichment medium for the isolation of Bordetella.

Authors:  J Regan; F Lowe
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

2.  The laboratory diagnosis of whooping cough by fluorescent antibody and by culture methods.

Authors:  N Chalvardjian
Journal:  Can Med Assoc J       Date:  1966-08-06       Impact factor: 8.262

3.  Preservation of nasopharyngeal smears for fluorescent antibody detection of Bordetella pertussis.

Authors:  P P Harris; B Thomason; R M McKinney
Journal:  J Clin Microbiol       Date:  1980-12       Impact factor: 5.948

4.  The IgM and IgG response to Bordetella pertussis vaccination and infection.

Authors:  M E Macaulay
Journal:  J Med Microbiol       Date:  1981-02       Impact factor: 2.472

5.  Purification and characterisation of a fimbrial haemagglutinin from Bordetella pertussis for use in an enzyme-linked immunosorbent assay.

Authors:  P Askelöf; M Granström; P Gillenius; A A Lindberg
Journal:  J Med Microbiol       Date:  1982-02       Impact factor: 2.472

6.  The serological diagnosis of whooping cough.

Authors:  M E Macaulay
Journal:  J Hyg (Lond)       Date:  1979-08

7.  Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen.

Authors:  M Granström; G Granström; A Lindfors; P Askelöf
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

8.  Enzyme-linked immunosorbent assay for detection of pertussis immunoglobulin A in nasopharyngeal secretions as an indicator of recent infection.

Authors:  Y E Goodman; A J Wort; F L Jackson
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

9.  Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA).

Authors:  M K Viljanen; O Ruuskanen; C Granberg; T T Salmi
Journal:  Scand J Infect Dis       Date:  1982

10.  Detection of Bordetella pertussis antibodies in human sera by complement-fixation and immunofluorescence.

Authors:  C M Bradstreet; A J Tannahill; J M Edwards; P F Benson
Journal:  J Hyg (Lond)       Date:  1972-03
View more
  25 in total

1.  Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.

Authors:  H E de Melker; F G Versteegh; M A Conyn-Van Spaendonck; L H Elvers; G A Berbers; A van Der Zee; J F Schellekens
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Analysis with a combination of macrorestriction endonucleases reveals a high degree of polymorphism among Bordetella pertussis isolates in eastern France.

Authors:  G Prevost; F I Freitas; P Stoessel; O Meunier; M Haubensack; H Monteil; J M Scheftel
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

3.  Office diagnosis of pertussis.

Authors:  S Halperin
Journal:  Can J Infect Dis       Date:  1992-09

4.  Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.

Authors:  Harry E Prince; Mary Lapé-Nixon; Jose Matud
Journal:  Clin Vaccine Immunol       Date:  2006-02

Review 5.  Laboratory diagnosis of pertussis: state of the art in 1997.

Authors:  F M Müller; J E Hoppe; C H Wirsing von König
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

Review 6.  Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory.

Authors:  M Ieven; H Goossens
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

7.  Use of a Chinese hamster ovary cell cytotoxicity assay for the rapid diagnosis of pertussis.

Authors:  S A Halperin; R Bortolussi; A Kasina; A J Wort
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

8.  Identification of Bordetella pertussis infection by shared-primer PCR.

Authors:  Z Li; D L Jansen; T M Finn; S A Halperin; A Kasina; S P O'Connor; T Aoyama; C R Manclark; M J Brennan
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  Diagnosis of community-acquired pertussis infection: comparison of both culture and fluorescent-antibody assays with PCR detection using electrophoresis or dot blot hybridization.

Authors:  Jairam R Lingappa; William Lawrence; Sheyla West-Keefe; Romesh Gautom; Brad T Cookson
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  Role of whole-cell pertussis vaccine in severe local reactions to the preschool (fifth) dose of diphtheria-pertussis-tetanus vaccine.

Authors:  D W Scheifele; G Bjornson; S H Halperin; L Mitchell; S Boraston
Journal:  CMAJ       Date:  1994-01-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.